{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-120352","form_type":"8-K","ticker":"ADGM","cik":"0002006986","company_name":"Adagio Medical Holdings, Inc.","filed_at":"2025-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.268988+00:00","generated_at":"2026-05-16T13:33:22.765472+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Adagio Medical expands board to seven, appoints former Medtronic EVP Sean Salmon","bullets":["Board increased from six to seven directors; Salmon appointed Class II director, term expiring at 2026 annual meeting.","Salmon served as Medtronic EVP and President of Cardiovascular Portfolio from Jan 2021 to Sep 2025.","Appointed to Audit and Compensation Committees; will receive standard non-employee director compensation.","Company entered into standard indemnification agreement with Salmon.","No arrangements or material transactions with any other person in connection with appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-120352","json":"https://secwatch.observer/filing/0001104659-25-120352.json","markdown":"https://secwatch.observer/filing/0001104659-25-120352.md","text":"https://secwatch.observer/filing/0001104659-25-120352.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2006986/000110465925120352/0001104659-25-120352-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2006986/000110465925120352/tm2533309d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:33:22.765472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}